SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-058569
Filing Date
2013-08-01
Accepted
2013-08-01 06:05:23
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13847_110q.htm 10-Q 758451
2 EX-31.1 a13-13847_1ex31d1.htm EX-31.1 11610
3 EX-31.2 a13-13847_1ex31d2.htm EX-31.2 12079
4 EX-32.1 a13-13847_1ex32d1.htm EX-32.1 8030
  Complete submission text file 0001104659-13-058569.txt   7321626

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT snta-20130630.xml EX-101.INS 614751
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20130630.xsd EX-101.SCH 59200
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20130630_cal.xml EX-101.CAL 42219
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20130630_lab.xml EX-101.LAB 932345
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20130630_pre.xml EX-101.PRE 433404
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20130630_def.xml EX-101.DEF 241290
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 131000754
SIC: 2834 Pharmaceutical Preparations